Back to the Future with Ubiquitin

Cell

Volumn 116, Issue 2, 2004, Pages 181-190

  Pickart, Cecile M ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; PROTEASOME; UBIQUITIN;

BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; LYSOSOME; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

MAMMALIA;

EID: 0842303313     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)01074-2     Document Type: Review

References (107)

1. Adams J. Proteasome inhibitors as new anticancer drugs. Curr. Opin. Oncol. 14:2002;628-634.
2. Aguilar R.C., Wendland B. Ubiquitin. not just for proteasomes anymore Curr. Opin. Cell Biol. 15:2003;1-7.
3. Amerik A.Y., Li S.-J., Hochstrasser M. Analysis of the deubiquitinating enzymes of the yeast Saccharomyces cerevisiae. Biol. Chem. 381:2000;981-992.
4. Ayusawa D., Kaneda S., Itoh Y., Yasuda H., Murakami Y., Sugasawa K., Hanaoka F., Seno T. Complementation by a cloned human ubiquitin-activating enzyme E1 of the S-phase-arrested mouse FM3A cell mutant with thermolabile E1. Cell Struct. Funct. 17:1992;113-122.
5. Bachmair A., Finley D., Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue. Science. 234:1986;179-186.
6. Bai C., Sen P., Hofmann K., Ma L., Goebl M., Harper J.W., Elledge S.J. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell. 86:1996;263-274.
7. Balakirev M.Y., Tcherniuk S.O., Jaquinod M., Chroboczek J. Otubains. a new family of cysteine proteases in the ubiquitin pathway EMBO Rep. 4:2003;517-522.
8. Baumeister W., Walz J., Zuhl F., Seemuller E. The proteasome. paradigm of a self-compartmentalizing protease Cell. 92:1998;367-380.
9. Bence N.F., Sampat R.M., Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 292:2001;1552-1555.
10. Berke S.J., Paulson H.L. Protein aggregation and the ubiquitin proteasome pathway. gaining the UPPer hand on neurodegeneration Curr. Opin. Genet. Dev. 13:2003;253-261.
11. Brooks C.L., Gu W. Ubiquitination, phosphorylation and acetylation. the molecular basis for p53 regulation Curr. Opin. Cell Biol. 15:2003;164-171.
12. Brummelkamp T.R., Nijman S.M.B., Dirac A.M.G., Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature. 424:2003;797-801.
13. Brzovic P.S., Keeffe J.R., Nishikawa H., Mayamoto K., Fox D., Fukuda M., Ohta T., Klevit R. Binding and recognition in the asembly of an active BRCA1-BARD1 ubiquitin ligase complex. Proc. Natl. Acad. Sci. USA. 100:2003;5646-5651.
14. Buchberger A. From UBA to UBX. new words in the ubiquitin vocabulary Trends Cell Biol. 12:2002;216-221.
15. Chau V., Tobias J.W., Bachmair A., Marriott D., Ecker D.J., Gonda D.K., Varshavsky A. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science. 243:1989;1576-1583.
16. Chen P., Johnson P., Sommer T., Jentsch S., Hochstrasser M. Multiple ubiquitin-conjugating enzymes participate in the in vivo degradation of the yeast MATα2 repressor. Cell. 74:1993;357-369.
17. Chin D.T., Kuehl L., Rechsteiner M. Conjugation of ubiquitin to denatured hemoglobin is proportional to the rate of hemoglobin degradation in HeLa cells. Proc. Natl. Acad. Sci. USA. 79:1982;5857-5861.
18. Ciechanover A., Finley D., Varshavsky A. Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell. 37:1984;57-66.
19. Ciechanover A., Heller H., Elias S., Haas A.L., Hershko A. ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation. Proc. Natl. Acad. Sci. USA. 77:1980;1365-1368.
20. Cohen M., Stutz F., Belgareh N., Haguenauer-Tsapis R., Dargemont C. Ubp3 requires a cofactor, Bre5, to specifically de-ubiquitinate the COPII protein, Sec23. Nat. Cell Biol. 5:2003;661-667.
21. Conaway R.C., Brower C.S., Conaway J.W. Emerging roles of ubiquitin in transcription regulation. Science. 296:2002;1254-1258.
22. Cyr D.M., Hohfeld J., Patterson C. Protein quality control. U-box-containing E3 ubiquitin ligases join the fold Trends Biochem. Sci. 27:2002;368-375.
23. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., Chen Z.J. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 103:2000;351-361.
24. Deshaies R.J. SCF and cullin/RING H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15:1999;435-467.
25. Deshaies R.J., Ferrell J.E. Multisite phosphorylation and the countdown to S phase. Cell. 107:2001;819-822.
26. Feldman R.M.R., Correll C.C., Kaplan K.B., Deshaies R.J. A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell. 91:1997;221-230.
27. Fersht A. Enzyme Structure and Mechanism. 1984;W.H. Freeman, New York.
28. Finley D., Ciechanover A., Varshavsky A. Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85. Cell. 37:1984;43-55.
29. Finley D., Sadis S., Monia B.P., Boucher P., Ecker D.J., Crooke S.T., Chau V. Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant. Mol. Cell. Biol. 14:1994;5501-5509.
30. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., Zavitz K.H., Wang H.E., Wettstein D.A., Stray K.M., Cote M., Rich R.L.et al. Tsg101 and the vaculolar protein sorting pathway are essential for HIV-1 budding. Cell. 107:2001;55-65.
31. Ghislain M., Udvardy A., Mann C. S. cerevisiae 26S protease mutants arrest cell division in G2/metaphase. Nature. 366:1993;358-362.
32. Giasson B.I., Lee V.M.-Y. Are ubiquitination pathways central to Parkinson's disease. Cell. 114:2003;1-8.
33. Glotzer M., Murray A.W., Kirschner M.W. Cyclin is degraded by the ubiquitin pathway. Nature. 349:1991;132-138.
34. Goldknopf I.L., Taylor C.W., Baum R.M., Yeoman L.C., Olson M.O., Prestayko A.W., Busch H. Isolation and characterization of protein A24, a "histone-like" non-histone chromosomal protein. J. Biol. Chem. 250:1975;7182-7187.
35. Gordon C., McGurk G., Dillon P., Rosen C., Hastie N.D. Defective mitosis due to a mutation in the gene for a fission yeast 26S protease subunit. Nature. 366:1993;355-357.
36. Gregory R.C., Taniguchi T., D'Andrea A.D. Regulation of the Fanconi anemia pathway by monoubiquitination. Semin. Cancer Biol. 13:2003;77-82.
37. Haas A.L., Warms J.V.B., Hershko A., Rose I.A. Ubiquitin-activating enzyme. Mechanism and role in protein-ubiquitin conjugation. J. Biol. Chem. 257:1982;2543-2548.
38. Heinemeyer W., Kleinschmidt J.A., Saidowsky J., Escher C., Wolf D.H. Proteinase yscE, the yeast proteasome/multicatalytic-multifunctional proteinase. mutants unravel its function in stress induced proteolysis and uncover its necessity for cell survival EMBO J. 10:1991;555-562.
39. Hershko A., Ciechanover A., Heller H., Haas A.L., Rose I.A. Proposed role of ATP in protein breakdown. conjugation of proteins with multiple chains of the polypeptide of ATP-dependent proteolysis Proc. Natl. Acad. Sci. USA. 77:1980;1783-1786.
40. Hershko A., Eytan E., Ciechanover A., Haas A.L. Immunochemical analysis of the turnover of ubiquitin-protein conjugates in intact cells. Relationship to the breakdown of abnormal proteins. J. Biol. Chem. 257:1982;13964-13970.
41. Hershko A., Ganoth D., Pehrson J., Palazzo R.E., Cohen L.H. Methylated ubiquitin inhibits cyclin degradation in clam embryo extracts. J. Biol. Chem. 266:1991;16376-16379.
42. Hershko A., Heller H., Elias S., Ciechanover A. Components of ubiquitin-protein ligase system. J. Biol. Chem. 258:1983;8206-8214.
43. Hershko A., Heller H., Eytan E., Kaklij G., Rose I.A. Role of the alpha-amino group of protein in ubiquitin-mediated protein breakdown. Proc. Natl. Acad. Sci. USA. 81:1984;7021-7025. a.
44. Hershko A., Leshinsky E., Ganoth D., Heller H. ATP-dependent degradation of ubiquitin-protein conjugates. Proc. Natl. Acad. Sci. USA. 81:1984;1619-1623. b.
45. Hicke L., Dunn R. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu. Rev. Cell Dev. Biol. 19:2003;141-172.
46. Hicke L., Riezman H. Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis. Cell. 84:1996;277-287.
47. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30:1996;405-439.
48. Hoege C., Pfander B., Moldovan G.-L., Pyrowolakis G., Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature. 419:2002;135-141.
49. Hofmann R.M., Pickart C.M. Noncanonical MMS2-encoded ubiquitin- conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell. 96:1999;645-653.
50. Hon W.C., Wilson M.I., Harlos K., Claridge T.D., Schofield C.J., Pugh C.W., Maxwell P.H., Ratcliffe P.J., Stuart D.D., Jones E.Y. Structural basis of the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature. 417:2002;975-978.
51. Hough R., Rechsteiner M. Ubiquitin-lysozyme conjugates. Purification and susceptibility to proteolysis. J. Biol. Chem. 261:1986;2391-2399.
52. Huang L., Kinnucan E., Wang G., Beaudenon S., Howley P.M., Huibregtse J.M., Pavletich N.P. Structure of an E6AP-UbcH7 complex. insights into ubiquitination by the E2-E3 enzyme cascade Science. 286:1999;1321-1326.
53. 2 sensing Science. 292:2001;464-468.
54. 2-regulated prolyl hydroxylation. Science. 292:2001;468-472.
55. Jackson P.K., Eldridge A.G., Freed E., Furstenthal L., Hsu J.Y., Kaiser B.K., Reimann J.D.R. The lore of the RINGs. substrate recognition and catalysis by ubiquitin ligases Trends Cell Biol. 10:2000;429-439.
56. Jason L.J., Moore S.C., Lewis J.D., Lindsey G., Ausio J. Histone ubiquitination. a tagging tail unfolds? Bioessays. 24:2002;166-174.
57. Joazeiro C.A.P., Weissman A.M. RING finger proteins. mediators of ubiquitin ligase activity Cell. 102:2000;549-552.
58. Johnson P.R., Swanson R., Rakhilina L., Hochstrasser M. Degradation signal masking by heterodimerization of MATalpha2 and MATa1 blocks their mutual destruction by the ubiquitin-proteasome pathway. Cell. 94:1998;217-227.
59. Kolling R., Hollenberg C.P. The ABC-transporter Ste6 accumulates in the plasma membrane in a ubiquitinated form in endocytosis mutants. EMBO J. 13:1994;3261-3271.
60. Kostova Z., Wolf D.H. For whom the bell tolls. protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection EMBO J. 22:2003;2309-2317.
61. Kovalenko A., Chable-Bessia C., Cantarella G., Israel A., Wallach D., Courtois G. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature. 424:2003;801-805.
62. Kwon Y.T., Kashina A.S., Davydov I.V., Hu R.-G., An J.Y., Seo J.W., Du F., Varshavsky A. An essential role of N-terminal arginylation in cardovascular development. Science. 297:2002;96-99.
63. Laney J.D., Hochstrasser M. Substrate targeting in the ubiquitin system. Cell. 97:1999;427-430.
64. Li M., Chen D., Shiloh A., Luo J., Nikolaev A.Y., Qin J., Gu W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature. 416:2002;648-653.
65. Loeb K.R., Haas A.L. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J. Biol. Chem. 267:1992;7806-7813.
66. Lorick K.L., Jensen J.P., Fang S., Ong A.M., Hatakeyama S., Weissman A.M. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA. 96:1999;11364-11369.
67. Marunouchi T., Yamada M., Matusumoto Y., Yamada M. Disappearance of a chromosomal basic protein from cells of a mouse temperature-sensitive mutant defective in histone phosphorylation. Biochem. Biophys. Res. Commun. 95:1980;126-131.
68. Min J.-H., Yang H., Ivan M., Gertler F., Kaelin W.G., Pavletich N.P. Structure of an HIF-1α-pVHL complex. hydroxyproline recognition in signaling Science. 296:2002;1886-1889.
69. Mita S., Yasuda H., Marunouchi T., Ishiko S., Yamada M. A temperature-sensitive mutant of cultured mouse cells defective in chromosome condensation. Exp. Cell Res. 126:1980;407-416.
70. Muller S., Hoege C., Pyrowolakis G., Jentsch S. SUMO, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell Biol. 2:2001;202-210.
71. Murray A.W. Recycling the cell cycle. cyclins revisited Cell. 116:2004;221-234. , this issue.
72. Nalepa G., Harper W. Therapeutic anti-cancer targets upstream of the proteasome. Cancer Treat. Rev. 29:2003;49-57.
73. Cdc4 ubiquitin ligase. Cell. 112:2003;243-256.
74. Ozkaynak E., Finley D., Varshavsky A. The yeast ubiquitin gene. head-to-tail repeats encoding a polyubiquitin precursor protein Nature. 312:1984;663-666.
75. Peng J., Schwartz D., Elias J.E., Thoreen C.C., Cheng D., Marsischky G., Roelofs J., Finley D., Gygi S.P. A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 21:2003;921-926.
76. Peters J.M. The anaphase-promoting complex. proteolysis in mitosis and beyond Mol. Cell. 9:2002;931-943.
77. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:2001;503-533.
78. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:1994;761-771.
79. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
80. Schwartz A.L., Ciechanover A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu. Rev. Med. 50:1999;57-74.
81. Schwartz D.C., Hochstrasser M. A superfamily of protein tags. ubiquitin, SUMO and related modifiers Trends Biochem. Sci. 28:2003;321-328.
82. Semple C.A. The comparative proteomics of ubiquitination in mouse. Genome Res. 13:2003;1389-1394.
83. Seol J.H., Feldman R.M., Zachariae W., Shevchenko A., Correll C.C., Lyapina S., Chi Y., Galova M., Claypool J., Sandmeyer S.et al. Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34. Genes Dev. 13:1999;1614-1626.
84. Seufert W., Jentsch S. Ubiquitin-conjugating enzymes UBC4 and UBC5 mediate selective degradation of short-lived and abnormal proteins. EMBO J. 9:1990;543-550.
85. Seufert W., Jentsch S. In vivo function of the proteasome in the ubiquitin pathway. EMBO J. 11:1992;3077-3080.
86. Shringarpure R., Grune T., Mehlhase J., Davies K.J.A. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J. Biol. Chem. 278:2003;311-318.
87. Simpson M.V. The release of labeled amino acids from the proteins of rat liver slices. J. Biol. Chem. 201:1953;143-154.
88. Skowyra D., Craig K.L., Tyers M., Elledge S.J., Harper J.W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell. 91:1997;209-219.
89. Song S., Kim S.-Y., Hong Y.-M., Jo D.-G., Lee J.-Y., Shim S.M., Chung C.-W., Seo S.J., Yoo Y.J., Koh J.-Y.et al. Essential role of E2-25K/Hip-2 in mediating amyloid-β toxicity. Mol. Cell. 12:2003;553-563.
90. Spence J., Gali R.R., Dittmar G., Sherman F., Karin M., Finley D. Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain. Cell. 102:2000;67-76.
91. Spence J., Sadis S., Haas A.L., Finley D. A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol. Cell. Biol. 15:1995;1265-1273.
92. Stebbins C.E., Kaelin W.G., Pavletich N.P. Structure of the VHL-ElonginC-ElonginB complex. implications for VHL tumor suppressor function Science. 284:1999;455-461.
93. Stelter P., Ulrich H.D. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature. 425:2003;188-191.
94. Strous G.J., van Kerkhof P., Govers R., Ciechanover A., Schwartz A.L. The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor. EMBO J. 15:1996;3806-3812.
95. Sun Z.-W., Allis C.D. Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast. Nature. 418:2002;104-108.
96. Trompouki E., Hatzivassiliou E., Tsichritzis T., Farmer H., Ashworth A., Mosialos G. CYLD is a deubiquitinating enzyme that negative regulates NF-κB activation by TNFR family members. Nature. 424:2003;793-796.
97. Varshavsky A. The N-end rule pathway of protein degradation. Genes Cells. 2:1997;13-28.
98. Verma R., Aravind L., Oania R., McDonald W.H., Yates J.R., Koonin E.V., Deshaies R.J. Role of Rpn11 metalloprotease motif in deubiquitination and degradation by the 26S proteasome. Science. 298:2002;611-615.
99. Vierstra R.D. The ubiquitin/26S proteasome pathway, the complex last chapter in the life of many plant proteins. Trends Plant Sci. 8:2003;135-142.
100. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J.-I., Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 412:2001;346-351.
101. Wang L., Fraley C.D., Faridi J., Kornberg A., Roth R.A. Inorganic polyphosphate stimulates mammalian TOR, a kinase involved in the proliferation of mammary cancer cells. Proc. Natl. Acad. Sci. USA. 100:2003;11249-11254.
102. Wolfenden R., Snider M.J. The depth of chemical time and the power of enzymes as catalysts. Acc. Chem. Res. 34:2001;938-945.
103. Wu P.-Y., Hanlon M., Eddins M., Tsui C., Rogers R., Jensen J.P., Matunis M.J., Weissman A.M., Wolberger C., Pickart C.M. A conserved catalytic residue in the E2 enzyme family. EMBO J. 22:2003;5241-5250.
104. Yao T., Cohen R.E. A cryptic protase couples deubiquitination and degradation by the 26S proteasome. Nature. 419:2002;403-407.
105. Yoshida Y., Chiba T., Tokunaga F., Kawasaki H., Iwai K., Suzuki T., Ito Y., Matsuoka K., Yoshida M., Tanaka K., Tai T. E3 ubiquitin ligase that recognizes sugar chains. Nature. 418:2002;438-442.
106. Skp2 SCF ubiquitin ligase complex. Nature. 416:2002;703-709.
107. Zheng N., Wang P., Jeffrey P.D., Pavletich N.P. Structure of a c-Cbl-UbcH7 complex. RING domain function in ubiquitin-protein ligases Cell. 102:2000;533-539.